Related Experiment Video
Updated: Jul 6, 2025
10:23
Author Spotlight: Computing the Effects of a Local Radiofrequency Hyperthermia Intervention on Tumor Biomechanics
Published on: December 1, 2023
444
Possible mechanisms and simulation modeling of FLASH radiotherapy
Yuta Shiraishi1,2, Yusuke Matsuya3, Hisanori Fukunaga4
1Graduate School of Health Sciences, Hokkaido University, N12 W5 Kita-Ku, Sapporo, Hokkaido, 060-0812, Japan.
Radiological Physics and Technology
|January 6, 2024
Summary
FLASH radiotherapy (ultra-high dose rate radiotherapy) shows promise for improving patient outcomes by reducing normal tissue toxicity while maintaining tumor control. Further research into its mechanisms and simulation modeling is ongoing.
Area of Science:
- Medical Physics
- Radiation Oncology
- Radiochemistry
Background:
- FLASH radiotherapy (FLASH-RT) utilizes ultra-high dose rates (UHDR) ≥ 40 Gy/s.
- It offers potential for higher tumor doses compared to conventional radiotherapy (0.01-0.40 Gy/s).
- The "FLASH effect" involves reduced normal tissue toxicity with preserved antitumor efficacy, but underlying mechanisms are unclear.
Purpose of the Study:
- To explore the mechanisms behind the FLASH effect.
- To discuss the clinical potential of FLASH-RT.
- To review the development of simulation models for FLASH-RT treatment planning.
Main Methods:
- Summary of physicochemical, chemical, and biological perspectives on FLASH-RT.
- Review of current simulation modeling approaches for FLASH-RT.
- Analysis of existing literature on UHDR irradiation effects.
Main Results:
- Potential mechanisms include transient oxygen depletion and enhanced secondary reactive species reactions.
- FLASH-RT demonstrates a unique therapeutic window.
- Simulation models are crucial for advancing FLASH-RT treatment planning.
Conclusions:
- Understanding FLASH-RT mechanisms is key to optimizing its clinical application.
- Further development of simulation models will aid in treatment planning and efficacy.
- FLASH-RT holds significant promise for improving cancer patient outcomes.
